Synapse - Sergio Giralt

Results (1053)

Dynamic easix scores closely predict non-relapse mortality after allogeneic hematopoietic cell transplantation

Meeting Abstract

Nawas, M. T.; Sanchez-Escamilla, M.; Devlin, S. M.; Maloy, M. A.; Giralt, S. A.; Perales, M. A.; Scordo, M.
Blood (2019)

Fulltext@MSK | Save

Cognitive impairment is associated with inferior survival and increased non-relapse mortality in older allogeneic hematopoietic cell transplant (alloHCT) recipients: A multicenter retrospective study

Meeting Abstract

Olin, R. L.; Fretham, C.; Pasquini, M. C.; Arora, M.; Bhatt, V. R.; Derman, B.; Giralt, S. A.; Huang, L. W.; Koll, T. T.; Lee, S. M.; more...
Blood (2019)

Fulltext@MSK | Save

The geriatric syndrome of sarcopenia impacts allogeneic hematopoietic cell transplantation outcomes in combination with multi-morbidity and functional impairment

Meeting Abstract

Lin, R. J.; Michaud, L.; Lobaugh, S. M.; Nakajima, R.; Elko, T. A.; Ruiz, J. D.; Sauter, C. S.; Dahi, P. B.; Maloy, M. A.; Perales, M. A.; more...
Blood (2019)

Fulltext@MSK | Save

Impact and safety of chimeric antigen receptor T cell therapy in vulnerable older patients with relapsed/refractory diffuse large B-cell lymphoma

Meeting Abstract

Lin, R. J.; Lobaugh, S. M.; Pennisi, M.; Chan, J. T.; Batlevi, Y.; Ruiz, J. D.; Elko, T. A.; Maloy, M. A.; Batlevi, C. L.; Dahi, P. B.; more...
Blood (2019)

Fulltext@MSK | Save

Long-term sustained minimal residual disease (MRD) negativity in multiple myeloma patients treated with lenalidomide maintenance therapy: A clinical and correlative phase 2 study

Meeting Abstract

Landgren, O.; Mastey, D.; Lesokhin, A. M.; Smith, E. L.; Shah, U. A.; Mailankody, S.; Hultcrantz, M.; Hassoun, H.; Lu, S. X.; Salcedo, M.; more...
Blood (2019)

Fulltext@MSK | Save

A phase II, multicenter study of high dose chemotherapy with autologous stem cell transplant followed by maintenance therapy with romidepsin for T-cell lymphoma

Meeting Abstract

Khan, N.; Shustov, A. R.; Khimani, F.; Shadman, M.; Cassaday, R. D.; Ruan, J.; Moskowitz, A. J.; Zelenetz, A. D.; Noy, A.; Straus, D. J.; more...
Blood (2019)

Fulltext@MSK | Save

Hematological count recovery in patients undergoing treatment with chimeric antigen receptor T cells (CAR T)

Meeting Abstract

Jain, T.; Knezevic, A.; Pennisi, M.; Ruiz, J. D.; Devlin, S. M.; Maloy, M. A.; Halton, E.; Diamonte, C.; Scordo, M.; Sauter, C. S.; more...
Blood (2019)

Fulltext@MSK | Save

MSKCC early experience using radiotherapy as a bridging strategy for relapsed diffuse large B cell lymphoma before CD19 CAR T therapy

Meeting Abstract

Imber, B.; Palomba, M. L.; DeSelm, C.; Batlevi, C. L.; Dahi, P. B.; Giralt, S. A.; Noy, A.; Park, J. H.; Sauter, C. S.; Scordo, M.; more...
Blood (2019)

Fulltext@MSK | Save

Early experience using radiotherapy as a salvage treatment for relapsed or refractory non-Hodgkin lymphomas following CD19 chimeric antigen receptor modified T-cell therapy

Meeting Abstract

Imber, B.; Palomba, M. L.; DeSelm, C.; Dahi, P. B.; Sauter, C. S.; Scordo, M.; Batlevi, C. L.; Park, J. H.; Shah, G. L.; Giralt, S. A.; more...
Blood (2019)

Fulltext@MSK | Save

Re-induction and targeted conditioning with anti-CD45 iodine ((131)I) apamistamab [Iomab-B] leads to high rates of transplantation and successful engraftment in older patients with active, relapsed or refractory (rel/ref) AML after failure of chemotherapy and targeted agents: Preliminary midpoint results from the prospective, randomized phase 3 Sierra Trial

Meeting Abstract

Gyurkocza, B.; Nath, R.; Stiff, P. J.; Agura, E.; Litzow, M.; Tomlinson, B.; Choe, H. K.; Abhyankar, S.; Seropian, S.; Chen, G. L.; more...
Blood (2019)

Fulltext@MSK | Save

Sergio Andres Giralt

Results (1053)

Meeting Abstract

Meeting Abstract

Meeting Abstract

Meeting Abstract

Meeting Abstract

Meeting Abstract

Meeting Abstract

Meeting Abstract

Meeting Abstract

Meeting Abstract